We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$13.2M
2
TSLA icon
Tesla
TSLA
+$12.9M
3
BIDU icon
Baidu
BIDU
+$11.9M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10M
5
AMED
Amedisys
AMED
+$8.89M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TGNA
201
DELISTED
TEGNA Inc
TGNA
$1.67M 0.13%
82,200
+44,123
+116% +$841K
XLV icon
202
State Street Health Care Select Sector SPDR ETF
XLV
$43.3B
$1.67M 0.13%
+12,000
New +$1.62M
CORZ icon
203
Core Scientific
CORZ
$6.75B
$1.67M 0.13%
92,869
-311,966
-77% -$4.58M
HROW icon
204
Harrow
HROW
$1.51B
$1.66M 0.13%
34,353
-26,472
-44% -$997K
CRWD icon
205
CrowdStrike
CRWD
$218B
$1.65M 0.13%
13,476
-8,820
-40% -$1M
PLTR icon
206
Palantir
PLTR
$413B
$1.65M 0.13%
9,029
-28,956
-76% -$4.69M
DELL icon
207
Dell
DELL
$293B
$1.62M 0.13%
11,430
-28,401
-71% -$3.68M
AD
208
Array Digital Infrastructure
AD
$3.05B
$1.62M 0.13%
32,338
-2,067
-6% -$128K
CCRN
209
DELISTED
Cross Country Healthcare
CCRN
$1.62M 0.13%
113,756
+22,252
+24% +$294K
NTST
210
NETSTREIT Corp
NTST
$2.1B
$1.61M 0.13%
89,023
-15,741
-15% -$285K
AAON icon
211
Aaon
AAON
$7.77B
$1.6M 0.12%
17,100
-38,400
-69% -$3.15M
REZI icon
212
Resideo Technologies
REZI
$3.95B
$1.57M 0.12%
36,461
+12,758
+54% +$399K
FLGT icon
213
Fulgent Genetics
FLGT
$527M
$1.56M 0.12%
69,193
+232
+0.3% +$4.78K
MDB icon
214
MongoDB
MDB
$32.1B
$1.56M 0.12%
5,033
+3,909
+348% +$1M
BRSL
215
Brightstar Lottery PLC
BRSL
$2.03B
$1.56M 0.12%
90,426
+18,391
+26% +$294K
VRE
216
DELISTED
Veris Residential
VRE
$1.54M 0.12%
101,220
-39,900
-28% -$593K
CI icon
217
Cigna
CI
$74.6B
$1.54M 0.12%
5,336
+526
+11% +$156K
ALK icon
218
Alaska Air
ALK
$5.58B
$1.54M 0.12%
+30,854
New +$1.72M
TSLA icon
219
Tesla
TSLA
$1.3T
$1.53M 0.12%
3,439
-37,085
-92% -$12.9M
MHK icon
220
Mohawk Industries
MHK
$9.22B
$1.51M 0.12%
11,680
-5,766
-33% -$714K
THC icon
221
Tenet Healthcare
THC
$21.1B
$1.5M 0.12%
7,396
-2,635
-26% -$468K
BROS icon
222
Dutch Bros
BROS
$9.26B
$1.5M 0.12%
28,609
+20,442
+250% +$1.29M
ONTO icon
223
Onto Innovation
ONTO
$15.3B
$1.49M 0.12%
+11,547
New +$1.24M
XLP icon
224
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.7B
$1.49M 0.12%
+19,030
New +$1.54M
PRAX icon
225
Praxis Precision Medicines
PRAX
$10.1B
$1.49M 0.12%
28,102
+8,202
+41% +$398K
7 8
9
10 11

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.